Phil Packer | Innovation Lead AMR and Vaccines
Innovate UK

Innovate UK has a One Health approach to AMR, funding SMEs and industry to develop new vaccines, antimicrobials and therapies for infectious disease in both man and animals.  In addition, solutions.  In addition, capabilities and technologies are supported in Infection, Prevention and Control to reduce further spread of antimicrobial resistance in the Human Health, Environment and Agri-sectors  I am the Innovation Lead on AMR and Vaccines at Innovate UK, developing & delivering funding calls, supporting workshops and strategy. This includes overseeing extant and new projects funded through IUK funding mechanisms such as the Biomedical Catalyst and SMART call. I also the technical lead on the IUK AMR Global programme and its Missions to various countries (including Germany, USA, India and Switzerland). I was the IUK lead in the design and set up of the AMR initiative PACE (Pathways to Antimicrobial Clinical Efficacy), a co-creation with LifeArc and the Medicines Discovery Catapult.  PACE is a UK, £30M, nationally coordinated programme that supports both academic and SME translation, integrated with the UK science base and the international community to contribute innovative and precision therapeutics and associated diagnostics to the global infectious disease pipeline in areas of unmet patient need (especially under-served communities). I now sit on the Joint Leadership Team of PACE. I am also the IUK lead for the delivery of a £50M DHSC, UK Vaccine Network programme delivering vaccine with outbreak potential in Low- and Middle-Income Countries. During the SARS-COV2 pandemic I was involved in the UK Governments Vaccine response. I work widely across government and the scientific community including:

• UK AMR Diagnostics Programme Board
• UKRI AMR Exec.
• AMR Funders Forum

• Input into the UK AMR National Action Plan
• BactiVac Network Management Oversight Board
• Co-Chair Norther Health Cluster: AMR Focus Group
• Provide support to the development of strategy and plans for the UKVN